Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
2.

Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.

Wright WF, Bejou N, Shields RK, Marr K, McCarty TP, Pappas PG.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00512-19. doi: 10.1128/AAC.00512-19. Print 2019 Aug.

PMID:
31345844
3.

Reply to Tascini, et al.

Lee RA, McCarty TP, Camins BC, Rodriguez JM, Pappas PG.

Clin Infect Dis. 2019 Jul 25. pii: ciz681. doi: 10.1093/cid/ciz681. [Epub ahead of print] No abstract available.

PMID:
31343697
4.

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.

Spec A, Pullman J, Thompson GR, Powderly WG, Tobin EH, Vazquez J, Wring SA, Angulo D, Helou S, Pappas PG; Mycoses Study Group .

J Antimicrob Chemother. 2019 Oct 1;74(10):3056-3062. doi: 10.1093/jac/dkz277.

PMID:
31304536
5.

Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Baddley JW, Thompson GR 3rd, Riley KO, Moore MK, Moser SA, Pappas PG.

Open Forum Infect Dis. 2019 May 20;6(6):ofz241. doi: 10.1093/ofid/ofz241. eCollection 2019 Jun.

6.

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study.

Nguyen MH, Clancy CJ, Pasculle AW, Pappas PG, Alangaden G, Pankey GA, Schmitt BH, Rasool A, Weinstein MP, Widen R, Hernandez DR, Wolk DM, Walsh TJ, Perfect JR, Wilson MN, Mylonakis E.

Ann Intern Med. 2019 Jun 18;170(12):845-852. doi: 10.7326/M18-2772. Epub 2019 May 14.

PMID:
31083728
7.

Histoplasmosis: Time to Redraw the Map and Up Our Game.

McKinsey DS, Pappas PG.

Clin Infect Dis. 2019 Apr 30. pii: ciz327. doi: 10.1093/cid/ciz327. [Epub ahead of print] No abstract available.

PMID:
31038169
8.

Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.

Lee RA, Scully MC, Camins BC, Griffin RL, Kunz DF, Moser SA, Hoesley CJ, McCarty TP, Pappas PG.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1419-1424. doi: 10.1017/ice.2018.245. Epub 2018 Oct 9.

PMID:
30296959
9.

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda L, Croos-Dabrera R, Fredericks C, Thompson GR.

Clin Infect Dis. 2019 May 30;68(12):1981-1989. doi: 10.1093/cid/ciy827.

PMID:
30289478
10.

Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With Candidemia.

Lee RA, Zurko JC, Camins BC, Griffin RL, Rodriguez JM, McCarty TP, Magadia J, Pappas PG.

Clin Infect Dis. 2019 Apr 24;68(9):1585-1587. doi: 10.1093/cid/ciy849.

PMID:
30281081
11.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017 Sep 26;4(4):ofx200. doi: 10.1093/ofid/ofx200. eCollection 2017 Fall.

12.

Invasive candidiasis.

Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ.

Nat Rev Dis Primers. 2018 May 11;4:18026. doi: 10.1038/nrdp.2018.26. Review.

PMID:
29749387
13.

Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.

McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, Pappas PG.

J Antimicrob Chemother. 2018 Jun 1;73(6):1677-1680. doi: 10.1093/jac/dky059.

PMID:
29506044
14.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
15.

Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.

Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM.

Transpl Infect Dis. 2018 Apr;20(2):e12855. doi: 10.1111/tid.12855. Epub 2018 Mar 6.

16.

Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.

Mylonakis E, Zacharioudakis IM, Clancy CJ, Nguyen MH, Pappas PG.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01756-17. doi: 10.1128/JCM.01756-17. Print 2018 Apr.

17.

Antibody and B Cell Subset Perturbations in Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis.

Rohatgi S, Nakouzi A, Carreño LJ, Slosar-Cheah M, Kuniholm MH, Wang T, Pappas PG, Pirofski LA.

Open Forum Infect Dis. 2017 Nov 18;5(1):ofx255. doi: 10.1093/ofid/ofx255. eCollection 2018 Jan.

18.

Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic.

Vasquez A, Zavasky D, Chow NA, Gade L, Zlatanic E, Elkind S, Litvintseva AP, Pappas PG, Perfect JR, Revankar S, Lockhart SR, Chiller T, Ackelsberg J, Vallabhaneni S.

Clin Infect Dis. 2018 Mar 5;66(6):959-962. doi: 10.1093/cid/cix948.

PMID:
29121235
19.

In Memorium: William Ernest Dismukes 1939-2017.

Pappas PG, Saag MS.

J Infect Dis. 2017 Sep 13. doi: 10.1093/infdis/jix480. [Epub ahead of print] No abstract available.

PMID:
28968670
20.

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.

Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T.

J Clin Microbiol. 2017 Dec;55(12):3324-3327. doi: 10.1128/JCM.01355-17. Epub 2017 Sep 13.

21.

Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study.

Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Benedict K, Murphy K, Pappas PG.

Open Forum Infect Dis. 2017 Mar 22;4(2):ofx050. doi: 10.1093/ofid/ofx050. eCollection 2017 Spring.

22.

The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, Bicanic TA, Castañeda E, Chang YC, Chen J, Cogliati M, Dromer F, Ellis D, Filler SG, Fisher MC, Harrison TS, Holland SM, Kohno S, Kronstad JW, Lazera M, Levitz SM, Lionakis MS, May RC, Ngamskulrongroj P, Pappas PG, Perfect JR, Rickerts V, Sorrell TC, Walsh TJ, Williamson PR, Xu J, Zelazny AM, Casadevall A.

mSphere. 2017 Jan 11;2(1). pii: e00357-16. doi: 10.1128/mSphere.00357-16. eCollection 2017 Jan-Feb.

23.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG; TRANSNET Investigators.

Transpl Infect Dis. 2016 Dec;18(6):921-931. doi: 10.1111/tid.12613. Epub 2016 Nov 14.

PMID:
27643395
24.

Reply to Simon and to Eljaaly and Nix.

Pappas PG, Kauffman CA, Andes DR.

Clin Infect Dis. 2016 Jul 15;63(2):287-8. doi: 10.1093/cid/ciw254. Epub 2016 Apr 24. No abstract available.

PMID:
27114379
25.

Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.

Gundacker ND, Jordan SJ, Jones BA, Drwiega JC, Pappas PG.

Open Forum Infect Dis. 2016 Feb 17;3(1):ofw038. doi: 10.1093/ofid/ofw038. eCollection 2016 Jan.

26.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
27.

Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature.

Medaris LA, Ponce B, Hyde Z, Delgado D, Ennis D, Lapidus W, Larrison M, Pappas PG.

Mycoses. 2016 Jun;59(6):334-42. doi: 10.1111/myc.12476. Epub 2016 Mar 10. Review.

PMID:
26968335
28.

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD.

Clin Infect Dis. 2016 Feb 15;62(4):409-17. doi: 10.1093/cid/civ1194. Review.

PMID:
26810419
29.

Comparison between liposomal formulations of amphotericin B.

Adler-Moore JP, Gangneux JP, Pappas PG.

Med Mycol. 2016 Mar;54(3):223-31. doi: 10.1093/mmy/myv111. Epub 2016 Jan 14. Review.

PMID:
26768369
30.

Invasive Candidiasis.

McCarty TP, Pappas PG.

Infect Dis Clin North Am. 2016 Mar;30(1):103-24. doi: 10.1016/j.idc.2015.10.013. Epub 2015 Dec 29. Review.

PMID:
26739610
31.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD.

Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.

32.

Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014.

McCotter OZ, Smith RM, Westercamp M, Kerkering TM, Malani AN, Latham R, Peglow SL, Mody RK, Pappas PG, Chiller TM.

MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1200-1. doi: 10.15585/mmwr.mm6442a4.

33.

A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.

Pettersen KD, Pappas PG, Chin-Hong P, Baxi SM.

BMJ Case Rep. 2015 Oct 16;2015. pii: bcr2015212108. doi: 10.1136/bcr-2015-212108.

34.

Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

White PL, Wingard JR, Bretagne S, Löffler J, Patterson TF, Slavin MA, Barnes RA, Pappas PG, Donnelly JP.

Clin Infect Dis. 2015 Oct 15;61(8):1293-303. doi: 10.1093/cid/civ507. Epub 2015 Jun 25. Review.

35.

Reply to Bauer and Goff.

Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG.

Clin Infect Dis. 2015 Aug 1;61(3):487-8. doi: 10.1093/cid/civ357. Epub 2015 May 5. No abstract available.

PMID:
25944341
36.

Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG; TRANSNET Investigators.

Med Mycol. 2015 Jun;53(5):440-6. doi: 10.1093/mmy/myv018. Epub 2015 Apr 23.

PMID:
25908651
37.

Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.

McCarty TP, Lee RA, Herfel BM, Pappas PG.

J Clin Virol. 2015 May;66:48-50. doi: 10.1016/j.jcv.2015.03.004. Epub 2015 Mar 7. Review.

PMID:
25866336
38.

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA.

Ann Intern Med. 2015 Jan 20;162(2):81-9. doi: 10.7326/M13-2508. Erratum in: Ann Intern Med. 2015 Mar 17;162(6):463. Ann Intern Med. 2019 Feb 5;170(3):220.

PMID:
25599346
39.

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG.

Clin Infect Dis. 2015 Mar 15;60(6):892-9. doi: 10.1093/cid/ciu959. Epub 2015 Jan 12.

PMID:
25586686
40.
41.

Antifungal clinical trials and guidelines: what we know and do not know.

Pappas PG.

Cold Spring Harb Perspect Med. 2014 Nov 3;4(11):a019745. doi: 10.1101/cshperspect.a019745. Review.

42.

Editorial commentary: An expanded role for therapeutic lumbar punctures in newly diagnosed AIDS-associated cryptococcal meningitis?

Pappas PG.

Clin Infect Dis. 2014 Dec 1;59(11):1615-7. doi: 10.1093/cid/ciu600. Epub 2014 Aug 6. No abstract available.

PMID:
25100866
43.

Race and invasive fungal infection in solid organ transplant recipients.

Boehme AK, McGwin G, Andes DR, Lyon GM, Chiller T, Pappas PG, Baddley JW.

Ethn Dis. 2014 Summer;24(3):382-5.

PMID:
25065083
44.

Epidemiology of invasive mold infections in lung transplant recipients.

Doligalski CT, Benedict K, Cleveland AA, Park B, Derado G, Pappas PG, Baddley JW, Zaas DW, Harris MT, Alexander BD.

Am J Transplant. 2014 Jun;14(6):1328-33. doi: 10.1111/ajt.12691. Epub 2014 Apr 11.

45.

Reversible blindness in cryptococcal meningitis with normal intracranial pressure: case report and review of the literature.

Ghatalia PA, Vick A, Vattoth S, Roberson GH, Pappas PG.

Clin Infect Dis. 2014 Jul 15;59(2):310-3. doi: 10.1093/cid/ciu216. Epub 2014 Apr 4. Review.

PMID:
24704725
46.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

47.

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.

Vazquez J, Reboli AC, Pappas PG, Patterson TF, Reinhardt J, Chin-Hong P, Tobin E, Kett DH, Biswas P, Swanson R.

BMC Infect Dis. 2014 Feb 21;14:97. doi: 10.1186/1471-2334-14-97.

48.

MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron MA, Schuster M, Judson MA, Revankar SG, Caeiro JP, Mangino JE, Mushatt D, Bedimo R, Freifeld A, Nguyen MH, Kauffman CA, Dismukes WE, Westfall AO, Deerman JB, Wood C, Sobel JD, Pappas PG.

Clin Infect Dis. 2014 May;58(9):1219-26. doi: 10.1093/cid/ciu074. Epub 2014 Feb 18.

PMID:
24550378
49.

Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature review.

Min Z, Moser SA, Pappas PG.

Med Mycol Case Rep. 2012 Dec 20;2:19-22. doi: 10.1016/j.mmcr.2012.12.004. eCollection 2012 Dec 20.

50.

Target lesions in a neutropenic patient.

Min Z, Pappas PG.

Intern Emerg Med. 2014 Aug;9(5):593-5. doi: 10.1007/s11739-013-1020-0. Epub 2013 Nov 30. No abstract available.

PMID:
24293213

Supplemental Content

Loading ...
Support Center